SciMax Global provides technology and consulting services for the pharmaceutical and life sciences industries, focusing exclusively on Scientific Communications and Medical Affairs. Its cloud-based SCIMAX platform helps organizations manage data, workflows, and programs, with automation, advanced insights, and managed cloud services. The company’s offerings include medical information and inquiry management, publication planning and management, sponsored trials, grants, sponsorships, and expanded access programs. Its solutions support processes such as submission, review, contracting, and close-out, while helping teams deliver scientific information consistently and compliantly.

SciMax also offers implementation, platform onboarding, and Medical Affairs process consulting, combining enterprise software expertise with domain knowledge. Its SCIMAX ARIN suite brings generative AI and intelligent automation to Medical Affairs workflows. AI capabilities include inquiry triage and case processing, response recommendations, content fulfilment, retrospective quality review, medical information chatbots, plain-language summary drafting, and journal and congress suggestions. SciMax Global serves a range of life sciences organizations, from emerging biotechnology companies to larger firms, as well as contact centers and agencies.